Isolation of a lactose-binding protein with monocyte/macrophage chemotactic activity

International Archives of Allergy and Immunology

Volumn 122, Issue 1, 2000, Pages 66-75

  Yamanaka, Tohru ^a   Saita, Naoki ^a   Kawano, Osamu ^a   Matsumoto, Mitsuhiro ^a   Kohrogi, Hirotsugu ^a   Suga, Moritaka ^a   Ando, Masayuki ^a   Hirashima, Mitsuomi ^b  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^b KAGAWA UNIVERSITY   (Japan)

Author keywords

Alveolar macrophages; Apoptosis; Chemotaxis; Galectin; Survival; TNF

Indexed keywords

COMPLEMENT COMPONENT C5A; LACTOSE; LACTOSE BINDING PROTEIN; MACROPHAGE CHEMOTACTIC FACTOR; MONOCYTE CHEMOTACTIC PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL TRANSFORMATION; CHEMOTAXIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; EOSINOPHIL; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS; LUNG ALVEOLUS MACROPHAGE; MACROPHAGE; MONOCYTE; NEUTROPHIL CHEMOTAXIS; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN ISOLATION; T LYMPHOCYTE;

EID: 0034027060     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000024360     Document Type: Article

References (36)

1. Snydermann R, Altman LC, Hausman MS, Mergenhagen SE: Human mononuclear leukocyte chemotaxis: A quantitative assay for mediators of humoral and cellular chemotactic factors. J Immunol 1972;108:857-860.
2. Yoshimura T, Robinson EA, Tanaka S, Appella E, Leonard EJ: Purification and amino acid analysis of two human monocyte chemoattractants produced by phytohemagglutinin-stimulated human mononuclear leukocytes. J Immunol 1989;142:1956-1962.
3. Sakata K, Tashiro K, Hirashima M, Hayashi H: Selective potentiation of macrophage chemotactic lymphokine production in complete Freund's adjuvant-treated guinea pigs. J Leukoc Biol 1989;46:144-154.
4. van Damme J, Proost P, Lenaerst JP, Opdenakker G: Structural and functional identification of two tumor-derived monocyte chemotactic proteins (MCP-2 and MCP-3) belonging to the chemotactic family. J Exp Med 1992;176:59-65.
5. Schall TJ, Bacon K, Toy KJ, Goeddel DV: Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 1990;347:669-671.
6. Fahey TJ 3rd, Tracey KJ, Tekamp-Olson P, Consens LS, Jones WG, Shires GT, Cerami A, Sherry B: Macrophage inflammatory protein-1 modulates macrophage function. J Immunol 1992;148:2764-2769.
7. Miller MD, Krangel MS: The human cytokine I-309 is a monocyte chemattractant. Proc Natl Acad Sci USA 1992;89:2950-2954.
8. O'Brien AD, Standiford TJ, Christensen PJ, Wilcoxon SE, Paine R 3rd: Chemotaxis of alveolar macrophages in response to signals derived from alveolar epithelial cells. J Lab Clin Med 1988;131:417-424.
9. Worgall S, Connor R, Kaner RJ, Fenamore E, Sheridan K, Singh R, Crystal RG: Expression and use of human immunodeficiency virus type 1 coreceptors by human alveolar macrophages. J Biol Chem 1999;73:5865-5874.
10. Perillo NL, Marcus ME, Baum LG: Galectins: Versatile modulators of cell adhesion, cell proliferation, and cell death. J Mol Med 1998;76:402-412.
11. Rabinuvich GA: Galectins: An evolutionarily conserved family of animal lectins with multi-functional properties; a trip from the gene to clinical therapy. Cell Death Differ 1999;6:711-721.
12. Matsumoto R, Matsumoto H, Seki M, Hata M, Asano Y, Kanegasaki S, Stevens LS, Hirashima M: Human ecalectin, a variant of human galectin-9, is a novel eosinophil chemattractant produced by T lymphocytes. J Biol Chem 1998; 273:16976-16984.
13. Matsushita N, Nishi N, Seki M, Matsumoto R, Kuwabara I, Liu F-T, Hata Y, Nakamura T, Hirashima M: Requirement of divalent galactoside-binding activity of ecalectin/galectin-9 for eosinophil chemattraction. J Biol Chem, in press.
14. Sugimoto M, Nakashima H, Matsumoto M, Uyama E, Ando M, Araki S: Pulmonary involvement in patients with HTLV-1 associated myelopathy: Increased soluble IL-2 receptors in bronchoalveolar lavage fluid. Am Rev Respir Dis 1989;139:1329-1335.
15. Falk W, Goodwin RHJr, Leonard EJ: A 48-well micro chemotaxis assembly for rapid and accurate measurement of leukocyte migration. J Immunol Methods 1980;33:239-247.
16. Hirashima M, Ueno M, Higuchi S, Matsumoto T, Sakata K-M, Matsumoto R, Adachi M: Establishment of a human T cell line constitutively producing several eosinophil chemotactic lymphokines and their functional heterogeneity of eosinophils. Lymphokine Cytokine Res 1992;6:331-338.
17. Hirashima M, Ueno M, Kamiya K, Higuchi S, Matsumoto R: Functional heterogeneity of human eosinophil chemotactic lymphokines. Lymphokine Cytokine Res 1991;10:481-486.
18. Nishiyama T, Hata T, Okada H, Hirashima M: Short-term stimulation with interleukin-4 enhances PPD-induced production of an eosinophil chemotactic lymphokine hut suppresses IL-5 production. Allergology Int 1998;47:37-43.
19. Evanoff HL, Burdick MD, Moore SA, Kunkel SL, Strieder RM: A sensitive ELISA for the detection of human monocyte chemoattractant protein-1 (MCP-1). Immunol Invest 1992;21:39-45.
20. Thornton SC, Robbins JM, Penny R, Breit SN: Fibroblast growth factors in connective tissue disease associated interstitial lung disease. Clin Exp Immunol 1992;90:447-452.
21. Zenetta J-P, Badache A, Maschke S, Marschal P, Kuehler S: Carbohydrates and soluble lectins in the regulation of cell adhesion and proliferation. Histol Histopathol 1994;9:385-412.
22. Dennis RP: A review of the biological significance of carbohydrates on glycoproteins and methods for their analysis. Glycoimmunology. New York, Plenum Press, 1995, pp 1-10.
23. Akimoto Y, Hirabayashi J, Kasai K, Hirano H: Expression of the endogenous 14-kDa beta-galactoside-binding lectin galectin in normal human skin. Cell Tissue Res 1995;280:1-10.
24. Moutsatsos IK, Wade M, Schindler M, Wang JL: Endogenous lectins from cultured cells: Nuclear localization of carbohydrate-binding protein 35 in proliferating 3T3 fibroblasts. Proc Natl Acad Sci USA 1987;84:6452-6456.
25. Saggioro D, Wang JM, Sironi M, Luini W, Mantovani A, Chieco-Bianchi L: Chemoattractant(s) in culture supernatants of HTLV-I-infected T-cell lines. AIDS Res Hum Retroviruses 1991;7:571-577.
26. Baba M, Imai T, Yoshida T, Yoshie O: Constitutive expression of various chemokine genes in human T-cell lines infected with human T-cell leukemia virus type I: Role of the viral transactivator Tax. Int J Cancer 1996;66:124-129.
27. Jiang Y, Beller DI, Frendl G, Graves DT: Monocyte chemoattractant protcin-1 regulates adhesion molecule expression and cytokine production in human monocytes. J Immunol 1992;148:2423-2428.
28. Kim HRC, Lin HM, Biliran H, Raz A: Cell cycle arrest and inhibition of anoikis by galectin-3 in human breast epitelial cells. Cancer Res 1999;59:4148-4154.
29. Yang RY, Hsu DK, Liu FT: Expression of galectin-3 modulates T cell growth and apoptosis. Proc Natl Acad Sci USA 1996;93:6737-6742.
30. Akahani S, Nangia-Makker P, Inohara H, Kim HRC, Raz A: Galectin-3: A novel antiapoptotic molecule wilh a functional BHI (NWGR) domain of Bcl-2 family. Cancer Res 1997;57:5272-5276.
31. Perillo NL, Pace KF, Seilhamer JJ, Baum LG: Apoptosis of T cells mediated by galectin-1. Nature 1995;378:736-739.
32. Wada J, Ota K, Kumar A, Wallner EI, Ksawar YS: Developmental regulation, expression, and apoptotic potential of galectin-9, a beta-galactoside binding lectin. J Clin Invest 1997;99:2452-2461.
33. Bingisser R, Stey C, Weller M, Groscurth P, Russi E, Frei K: Apoptosis in human alveolar macrophages is induced by endotoxin and is modulated by cytokines. Am J Respir Cell Mol Biol 1996;15:64-70.
34. Losa Garcia JE, Mateos Rodriquez F, Jimenez Lopez A, Garcia Salgado MJ, Martin De Cabo MR, Perez Losada J, Perez Arellano JL: Effect of cyclosporin A on inflammatory cytokine production by human alveolar macrophages. Respir Med 1998;92:722-728.
35. Poulakis N, Androutsos G, Kazi D, Bastas A, Provata A, Bitsakou C, Kontozolou T, Polyzogopolou C, Tassiopoulou A: The differential effect of pentoxifylline on cytokine production by alveolar macrophages and its clinical implications. Respir Med 1999;93:52-57.
36. Perkins RC, Scheule RK, Hamilton R, Gomes G, Freidman G, Holian A: Human alveolar macrophage cytokine release in response to in vitro and in vivo asbestos exposure. Exp Lung Res 1993;19:55-65.